Tomasz Glogowski

Potential Effects of Immunosuppression on Oxidative Stress and Atherosclerosis in Kidney Transplant Recipients

J. Małyszko, M. Kwiatkowska, E. Wojtaszek, 2021, Oxidative medicine and cellular longevity.

Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation

J. Małyszko, M. Kwiatkowska, E. Wojtaszek, 2021, Oxidative medicine and cellular longevity.

Transplant Renal Artery Stenosis: Underrecognized, Not So Rare, but Curable Complication.

R. Maciag, J. Małyszko, T. Grochowiecki, 2022, Transplantation proceedings.

Kidney Transplant Recipients Have Higher Malignancy Prevalence Than Hemodialyzed Patients.

J. Małyszko, M. Wieliczko, M. Pyrża, 2022, Transplantation proceedings.

[Cardiac surgery associated acute kidney injury].

E. Wojtaszek, Tomasz Glogowski, 2015, Wiadomosci lekarskie.

Iron and Chronic Kidney Disease: Still a Challenge

J. Małyszko, E. Wojtaszek, Tomasz Glogowski, 2020, Frontiers in Medicine.

Iron status and anemia control are related to peritoneal membrane properties in peritoneally dialyzed patients

J. Małyszko, E. Wojtaszek, Tomasz Glogowski, 2023, Frontiers in medicine.

Patients’ and healthcare personnel expectations for SARS-CoV-2 screening in dialysis unit during the Covid-19 pandemic

E. Wojtaszek, J. Przedlacki, P. Żebrowski, 2020, Journal of Nephrology.

Malignancy Prevalence in the Dialyzed Population and in Waitlisted Potential Kidney Transplant Recipients.

R. Stec, J. Małyszko, S. Nazarewski, 2022, Transplantation proceedings.

Influence of formalized Predialysis Education Program (fPEP) on the chosen and definitive renal replacement therapy option.

J. Małyszko, J. Matuszkiewicz-Rowińska, E. Wojtaszek, 2022, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

Prevalence of Cognitive Impairment in Peritoneal Dialysis Patients and Associated Factors

N. Zolek, J. Małyszko, E. Wojtaszek, 2023, Kidney and Blood Pressure Research.